Click here to sign up for the Nova Scotia Health Innovation Hub newsletter and never miss an update 

Nova Scotia Health Website

Atlantic Cancer Consortium

The Atlantic Cancer Consortium (ACC) was conceptualized in 2018 as a part of Marathon of Hope Cancer Centres Network (MOHCCN), a pan-Canadian initiative led by the Terry Fox Foundation and the Terry Fox Research Institute (TFRI) with the support of partner institutions across the Atlantic region

The Atlantic Cancer Consortium (ACC) was conceptualized in 2018 as a part of Marathon of Hope Cancer Centres Network (MOHCCN), a pan-Canadian initiative led by the Terry Fox Foundation and the Terry Fox Research Institute (TFRI) with the support of partner institutions across the Atlantic region. Focusing on precision medicine, ACC will harness the power and productivity of our leading Atlantic cancer research community to improve cancer diagnoses, predict how different people will respond to treatments, and deliver more personalized and effective treatments for the cancer patients.

Launched in January 2021 as part of TFRI’s vision to accelerate precision medicine for all Canadians, ACC is the fourth pilot project after BC-Ontario, Montreal, Prairies Cancer research consortia. The ACC pilot project will receive $3.6 million over the next two years, including a contribution of $1.5 million from TFRI. Upon completion of the pilot project, participating institutions will have a chance to apply to apply to be full members of the MOHCCN.